Agios Pharmaceuticals (AGIO) Crumbles: Stock Falls by 6.0% – Tale of the Tape

Zacks

Agios Pharmaceuticals, Inc. (AGIO) saw a big move last session, as the company’s shares fell nearly 6% on the day. The move came on pretty good volume too with far more shares changing hands than in a normal session. This reverses the recent trend for AGIO as the stock is now up around 16.0% in the past one-month time frame.

The company has seen a flat track record when it comes to current year estimate revisions over the past few weeks. The consensus for earnings hasn’t been in a trend either. This recent price action is discouraging, so make sure to keep a close watch on this firm in the near future, and especially on earnings estimates following the recent slump.

AGIO currently has a Zacks Rank #5 (Sell) while its Earnings ESP is 0.00%.

Some better-ranked stocks in the health care sector include Quidel Corp. (QDEL), Venaxis, Inc. (APPY) and William Demant Holding A/S (WILYY). All these stocks carry a Zacks Rank #2 (Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>

To read this article on Zacks.com click here.

Get all Zacks Research Reports and be alerted to fast-breaking buy and sell opportunities every trading day.

Be the first to comment

Leave a Reply